SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 66 filers reported holding SYROS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $204,000 | -85.0% | 211,820 | -81.4% | 0.00% | – |
| Q1 2022 | $1,356,000 | -63.8% | 1,139,351 | -0.8% | 0.00% | – |
| Q4 2021 | $3,746,000 | -24.9% | 1,148,939 | +3.0% | 0.00% | – |
| Q3 2021 | $4,987,000 | -8.4% | 1,115,572 | +11.6% | 0.00% | – |
| Q2 2021 | $5,446,000 | -8.5% | 999,254 | +25.6% | 0.00% | – |
| Q1 2021 | $5,949,000 | -24.6% | 795,345 | +9.4% | 0.00% | – |
| Q4 2020 | $7,887,000 | -47.5% | 726,939 | -57.2% | 0.00% | -100.0% |
| Q3 2020 | $15,023,000 | +66.8% | 1,699,482 | +101.1% | 0.00% | 0.0% |
| Q2 2020 | $9,009,000 | +132.6% | 845,149 | +29.4% | 0.00% | – |
| Q1 2020 | $3,873,000 | -17.9% | 653,131 | -4.4% | 0.00% | – |
| Q4 2019 | $4,719,000 | -32.6% | 682,962 | +1.3% | 0.00% | -100.0% |
| Q3 2019 | $6,999,000 | +34.2% | 674,261 | +19.7% | 0.00% | – |
| Q2 2019 | $5,216,000 | +35.6% | 563,332 | +33.8% | 0.00% | – |
| Q1 2019 | $3,847,000 | +68.4% | 420,892 | +2.6% | 0.00% | – |
| Q4 2018 | $2,284,000 | -49.8% | 410,119 | +7.4% | 0.00% | – |
| Q3 2018 | $4,550,000 | +26.8% | 381,882 | +8.6% | 0.00% | – |
| Q2 2018 | $3,589,000 | +37.1% | 351,767 | +74.4% | 0.00% | – |
| Q1 2018 | $2,618,000 | +41.0% | 201,742 | +5.8% | 0.00% | – |
| Q4 2017 | $1,857,000 | -34.4% | 190,643 | -0.9% | 0.00% | – |
| Q3 2017 | $2,832,000 | +3.8% | 192,436 | +13.5% | 0.00% | – |
| Q2 2017 | $2,728,000 | +179.5% | 169,497 | +176.7% | 0.00% | – |
| Q1 2017 | $976,000 | +76.2% | 61,247 | +34.8% | 0.00% | – |
| Q4 2016 | $554,000 | +59.7% | 45,447 | +81.9% | 0.00% | – |
| Q3 2016 | $347,000 | – | 24,979 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 3,439,895 | $18,747,000 | 4.66% |
| Bain Capital Life Sciences Investors, LLC | 5,785,036 | $31,528,000 | 2.07% |
| Omega Fund Management, LLC | 2,274,831 | $12,398,000 | 1.40% |
| Altium Capital Management LP | 1,076,942 | $5,869,000 | 1.36% |
| Samsara BioCapital, LLC | 2,189,199 | $10,599,000 | 1.31% |
| Sio Capital Management, LLC | 800,000 | $4,360,000 | 1.08% |
| Flagship Pioneering Inc. | 2,938,494 | $16,015,000 | 0.20% |
| EcoR1 Capital, LLC | 1,000,000 | $5,450,000 | 0.20% |
| Artal Group S.A. | 1,700,000 | $9,265,000 | 0.19% |
| ACT CAPITAL MANAGEMENT, LLC | 52,500 | $287,000 | 0.15% |